Increased Prevalence of Masked Blood Pressure Elevations in Treated Diabetic Subjects
Iddo Z. Ben-Dov, MD;
Drori Ben-Ishay, MD;
Judith Mekler, MSc;
Liora Ben-Arie;
Michael Bursztyn, MD
Arch Intern Med. 2007;167(19):2139-2142.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Hypertensive-type target organ damage is increased in patients with diabetes mellitus compared with blood pressure–matched individuals with euglycemia.1-8 Hyperglycemia and accompanying metabolic abnormalities partly explain this gap.9 Another possible explanation is a lower sensitivity of clinic blood pressure measurements in diabetic patients.10-11 Failure of clinic measurements to detect out-of-office elevated blood pressure results in the recently characterized entity of "masked hypertension," also known as isolated ambulatory hypertension and reverse white-coat hypertension, in which "true" blood pressure is underestimated and thus undertreated (among subjects with treated hypertension, these terms refer to masked uncontrolled hypertension12). The prognostic consequences of masked hypertension are similar to those of sustained hypertension.13-14 Several studies have documented a higher level of target organ damage among subjects with treated hypertension and "masked" blood pressure elevation, namely, misleadingly controlled clinic blood pressure.15-18
. . . [Full Text of this Article] Methods
Results
Comment
AUTHOR INFORMATION
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
White-Coat Hypertension Should Not Be Treated in Subjects With Diabetes
Bursztyn and Ben-Dov
Diabetes Care 2009;32:S310-S313.
FULL TEXT
Diabetes Mellitus and 24-Hour Ambulatory Blood Pressure Monitoring: Broadening Horizons of Risk Assessment
Bursztyn and Ben-Dov
Hypertension 2009;53:110-111.
FULL TEXT
|
